Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth/Experiment 24

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-9-16

Curated date: 2025/05/10

Curator: Ameenatoloko

Revision editor(s): Ameenatoloko, KateRasheed

Subjects

Location of subjects
United Kingdom
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Place of residence measurement Place of residence measurement,place of residence measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
The Barking, Havering and Redbridge University Hospitals NHS Trust and the University College London Hospitals NHS Foundation Trust (BHR + UCLH) on day 21
Group 1 name Corresponds to the case (exposed) group for case-control studies
The University Hospitals Leicester NHS Trust (LEI) on day 21
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Babies born in the University Hospitals Leicester NHS Trust (LEI) from May 2014 to December 2017.

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.25
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
Confounders controlled for: "hospital site" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.hospital site


Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-9-16

Curated date: 2025/05/10

Curator: Ameenatoloko

Revision editor(s): Ameenatoloko

Source: Table S5

Description: Significant metagenomic species associated with clinical covariates after adjusting for potentially confounding covariates with MaAsLin.

Abundance in Group 1: decreased abundance in The University Hospitals Leicester NHS Trust (LEI) on day 21

NCBI Quality ControlLinks
Klebsiella pneumoniae
Veillonella parvula

Revision editor(s): Ameenatoloko